Comments close next Monday on the CMS rule giving Medicare drug plans 72 hours to answer prior authorization
Medicare beneficiaries waiting on drug approvals, and the health plans that process those requests, face a fast-approaching deadline. The public comment period for a proposed CMS rule that would formally require Medicare drug plans to resolve most prior authorization decisions within 72 hours closes next Monday. The proposal, designated CMS-0062-P, also sets a 24-hour clock…